PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
PACT - Public Activities Coordination Tool
The public activities coordination tool (PACT) provides an overview of the substance-specific activities that authorities are working on under REACH and the CLP Regulation. These activities are being carried out in line with ECHA’s Integrated Regulatory Strategy.
PACT provides up-to-date information on the activities planned, ongoing or completed by ECHA and/or MSCAs for a given substance in the following areas:
- Data generation and assessment – dossier evaluation, substance evaluation, informal hazard assessment (PBT/vPvB/ED).
- Assessment of regulatory needs (ARN).
- Regulatory risk management – harmonised classification and labelling (CLH) , SVHC identification, recommendations for inclusion in the Authorisation List, restriction.
A summary of all the substance-specific activities can be found under ‘Details’ for each entry.
Further information
- Understanding PACT
- Integrated Regulatory Strategy
- Substances of potential concern
- Dossier Evaluation status
- Substance evaluation
- Endocrine disruptor assessment
- PBT assessment
- Assessment of regulatory needs list
- Registry of CLH intentions until outcome
- Registry of SVHC intentions until outcome
- Recommendations for inclusion in the Authorisation list
- Registry of restriction intentions until outcome
Filter the list
The List does not contain any Substances.
| Data generation and assessment | ARN | Regulatory risk management | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fatty acids, tall-oil, reaction products with boric acid (H3BO3) and diethanolamine | 294-785-9 | 91770-03-5 | - | - | 1 | - | - | - | - | - | - | Details |
| Amines, bis(hydrogenated tallow alkyl), 2-[[bis(hydrogenated tallow alkyl)amino]carbonyl]benzoates | 294-705-2 | 91745-35-6 | - | - | 3 | - | - | - | - | - | - | Details |
| Glycerides, rape-oil mono-, di- and tri-, hydrogenated | 294-661-4 | 91744-94-4 | - | - | - | - | 1 | - | - | - | - | Details |
| 9-Octadecenoic acid, 12-hydroxy-, [R-(Z)]-, mono- and diester with glycerol | 294-606-4 | 91744-44-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Glycerides, C8-10 mono-, di- and tri- | 294-594-0 | 91744-32-0 | - | - | - | - | 1 | - | - | - | - | Details |
| Glycerides, C12-18 di- and tri- | 294-590-9 | 91744-28-4 | - | - | - | - | 1 | - | - | - | - | Details |
| Glycerides, castor-oil mono-, di- and tri- | 294-589-3 | 91744-27-3 | - | - | - | - | 1 | - | - | - | - | Details |
| Glycerides, C16-18 and C18-unsatd. mono-, di and tri- | 294-582-5 | 91744-20-6 | - | - | 1 | - | 1 | - | - | - | - | Details |
| Glycerides, C16-18 and C18-unsatd. mono- | 294-571-5 | 91744-09-1 | - | - | 3 | - | 1 | - | - | - | - | Details |
|
Lavender, Lavandula hybrida, ext.
Extractives and their physically modified derivatives such as tinctures, concretes, absolutes, essential oils, oleoresins, terpenes, terpene-free fractions, distillates, residues, etc., obtained from Lavandula hybrida, Labiatae.
|
294-470-6 | 91722-69-9 | - | - | - | - | - | 1 | - | - | - | Details |